Status: current, Defined. Date: 31-Mar 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3056141000168111 | Praluent (alirocumab 75 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3056151000168113 | Praluent 75 mg/mL injection, syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Praluent (alirocumab 75 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Praluent (alirocumab 75 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Praluent (alirocumab 75 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | Is a | Praluent | true | Inferred relationship | Some | ||
| Praluent (alirocumab 75 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | Is a | alirocumab 75 mg/mL injection, syringe | true | Inferred relationship | Some | ||
| Praluent (alirocumab 75 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
| Praluent (alirocumab 75 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | has unit of use | syringe | true | Inferred relationship | Some | 81913207 | |
| Praluent (alirocumab 75 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | has Australian BoSS | alirocumab | true | Inferred relationship | Some | 81913206 | |
| Praluent (alirocumab 75 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | has intended active ingredient | alirocumab | true | Inferred relationship | Some | 81913206 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Praluent (alirocumab 75 mg / 1 mL) injection, 6 x 1 mL syringes (trade product pack) | has TPUU | True | Praluent (alirocumab 75 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | Inferred relationship | Some | 1 |
| Praluent 75 mg/mL injection, 1 mL syringe | has TPUU | True | Praluent (alirocumab 75 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | Inferred relationship | Some | 1 |
| Praluent 75 mg/mL injection, 6 x 1 mL syringes | has TPUU | True | Praluent (alirocumab 75 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | Inferred relationship | Some | 1 |
| Praluent 75 mg/mL injection, 2 x 1 mL syringes | has TPUU | True | Praluent (alirocumab 75 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | Inferred relationship | Some | 1 |
| Praluent 75 mg/mL injection, 1 mL syringe | has TPUU | True | Praluent (alirocumab 75 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | Inferred relationship | Some | 1 |
| Praluent 75 mg/mL injection, 2 x 1 mL syringes | has TPUU | True | Praluent (alirocumab 75 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR